Clinical Features of Crohn’s Disease Stratified by Age at Diagnosis According to Montreal Classification

References

• Joana Torres SMJC, Mehandru S, Colombel J-F, Peyrin-Biroulet L. Crohn’s disease. Lancet. 2017;389:1741–1755. doi:10.1016/S0140-6736(16)31711-1
   Web of Science ®Google Scholar
• Zhulina Y, Udumyan R, Henriksson I, et al. Temporal trends in non-stricturing and non-penetrating behaviour at diagnosis of Crohn’s disease in Örebro, Sweden: a population-based retrospective study. J Crohn’s Colitis. 2014;8(12):1653–1660. doi:10.1016/j.crohns.2014.07.006
   Google Scholar
• Ye Y, Manne S, Treem WR, et al. Prevalence of inflammatory bowel disease in pediatric and adult populations: recent estimates from large national databases in the United States, 2007–2016. Inflamm Bowel Dis. 2019. doi:10.1093/ibd/izz182
   Web of Science ®Google Scholar
• Lv H, Jin M, Zhang H, et al. Increasing newly diagnosed inflammatory bowel disease and improving prognosis in China: a 30-year retrospective study from a single centre. BMC Gastroenterol. 2020;20(1). doi:10.1186/s12876-020-01527-1
   Web of Science ®Google Scholar
• Bai X, Zhang H, Ruan G, et al. Long-term disease behavior and surgical intervention analysis in hospitalized patients with Crohn’s disease in china: a retrospective cohort study. Inflamm Bowel Dis. 2022;28(Supplement_2):S35–41. doi:10.1093/ibd/izab295
   Web of Science ®Google Scholar
• Ministro P, Dias CC, Portela F, et al. Age at diagnosis is determinant for the outcome of inflammatory bowel disease: is it a Myth? Clin Transl Gastroenterol. 2021;12(2):e309. doi:10.14309/ctg.0000000000000309
   Web of Science ®Google Scholar
• Tang WJ, Shi P, Zheng CF, et al. Special clinical characteristics and outcomes in Chinese pediatric patients with early‐onset Crohn’s disease. J Digest Dis. 2019;20(10):539–546. doi:10.1111/1751-2980.12803
   Web of Science ®Google Scholar
• Lichtenstein GR, Shahabi A, Seabury SA, et al. Lifetime economic burden of Crohn’s disease and ulcerative colitis by age at diagnosis. Clin Gastroenterol H. 2020;18(4):889–897. doi:10.1016/j.cgh.2019.07.022
   PubMed Web of Science ®Google Scholar
• Satsangi J. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. GUT. 2006;55(6):749–753. doi:10.1136/gut.2005.082909
   PubMed Web of Science ®Google Scholar
• Wang H, Wu Y, Ye C, et al. Perianal disease onset age is associated with distinct disease features and need for intestinal resection in perianal Crohn’s disease: a ten-year hospital-based observational study in China. Bmc Gastroenterol. 2021;21(1). doi:10.1186/s12876-021-01961-9
   Web of Science ®Google Scholar
• Day AS. Crohn’s and colitis in children and adolescents. World J Gastroentero. 2012;18(41):5862. doi:10.3748/wjg.v18.i41.5862
   Web of Science ®Google Scholar
• Inflammatory Bowel Disease Group CSOG, Association. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018), Beijing. J Digest Dis. 2021;22(6):298–317. doi:10.1111/1751-2980.12994
   Web of Science ®Google Scholar
• Gomollón F, Dignass A, Annese V, et al. European evidence-based consensus on the diagnosis and management of Crohn’s Disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2016;11(1):3–25. doi:10.1093/ecco-jcc/jjw168
   Google Scholar
• Kim HJ, Oh SH, Kim DY, et al. Clinical characteristics and long-term outcomes of paediatric Crohn’s disease: a single-centre experience. J Crohn’s Colitis. 2017;11(2):157–164. doi:10.1093/ecco-jcc/jjw146
   Google Scholar
• Moon JM, Kang EA, Han K, et al. Trends and risk factors of elderly-onset Crohn’s disease: a nationwide cohort study. World J Gastroentero. 2020;26(4):404–415. doi:10.3748/wjg.v26.i4.404
   Web of Science ®Google Scholar
• Cantoro L, Lenti MV, Monterubbianesi R, et al. Early‐onset versus late‐onset Crohn’s disease: an Italian cohort study. United Eur Gastroent. 2020;8(1):52–58. doi:10.1177/2050640619860661
   PubMed Web of Science ®Google Scholar
• Feagins LA, Spechler SJ. Biologic agent use varies inversely with age at diagnosis in Crohn’s disease. Digest Dis Sci. 2010;55(11):3164–3170. doi:10.1007/s10620-010-1397-9
   Web of Science ®Google Scholar
• Viola A, Monterubbianesi R, Scalisi G, et al. Late-onset Crohn’s disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease ‘AGED’ study. Eur J Gastroen Hepat. 2019;31(11):1361–1369. doi:10.1097/MEG.0000000000001546.
   Web of Science ®Google Scholar
• Viazis N, Pontas C, Karmiris K, et al. Prevalence of Clostridium difficile infection among hospitalized inflammatory bowel disease patients in Greece. Eur J Gastroen Hepat. 2019;31(7):773–776. doi:10.1097/MEG.0000000000001414
   Web of Science ®Google Scholar
• Palacios Argueta P, Salazar M, Attar B, et al. 90-Day specific readmission for clostridium difficile infection after hospitalization with an inflammatory bowel disease flare: outcomes and risk factors. Inflamm Bowel Dis. 2021;27(4):530–537. doi:10.1093/ibd/izaa224
   Web of Science ®Google Scholar
• Hellmann J, Andersen H, Fei L, et al. Microbial shifts and shorter time to bowel resection surgery associated with C. difficile in pediatric Crohn’s disease. Inflamm Bowel Dis. 2019. doi:10.1093/ibd/izz263
   Web of Science ®Google Scholar
• Mengque X. Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease. Biomed Res Int. 2019;2019:1–7. doi:10.1155/2019/6517549.
   Web of Science ®Google Scholar
• Argeny S, Stift A, Bergmann M, et al. Prognostic value of preoperative neutrophil-to-lymphocyte ratio in Crohn’s disease. Wien Klin Wochenschr. 2018;130(11–12):398–403. doi:10.1007/s00508-018-1322-3
   PubMed Web of Science ®Google Scholar
• Irwin JR, Ferguson E, Simms LA, et al. Detectable laboratory abnormality is present up to 12 months prior to diagnosis in patients with crohn’s disease. Digest Dis Sci. 2019;64(2):503–517. doi:10.1007/s10620-018-5357-0
   Web of Science ®Google Scholar
• Ashton JJ, Borca F, Mossotto E, et al. Analysis and hierarchical clustering of blood results before diagnosis in pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2018. doi:10.1093/ibd/izy369
   Web of Science ®Google Scholar
• Ferreiro B, Llopis-Salinero S, Lardies B, et al. Clinical and nutritional impact of a semi-elemental hydrolyzed whey protein diet in patients with active Crohn’s disease: a prospective observational study. Nutrients. 2021;13(10):3623. doi:10.3390/nu13103623
   Web of Science ®Google Scholar
• Shen J, Ran ZH, Zhang Y, et al. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis. Thromb Res. 2009;123(4):604–611. doi:10.1016/j.thromres.2008.04.004
   Web of Science ®Google Scholar
• Li Y, Jian AR, Ge FW, et al. Impaired coagulation status in the Crohn’ s disease patients complicated with intestinal fistula. Chinese Med J-Peking. 2018;131(5). doi:10.4103/0366-6999.226072
   Web of Science ®Google Scholar
• Hwang SW, Kim JH, Im JP, et al. Influence of age at diagnosis on the clinical characteristics of Crohn’s disease in Korea: results from the CONNECT study. J Gastroen Hepatol. 2017;32(10):1716–1722. doi:10.1111/jgh.13775
   Web of Science ®Google Scholar
• Dhaliwal J, Walters TD, Mack DR, et al. Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the Canadian children IBD network. J Crohn’s Colitis. 2020;14(4):445–454. doi:10.1093/ecco-jcc/jjz106
   Google Scholar
• Park SH, Im JP, Park H, et al. Clinical features and long-term outcomes of paediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong District of Seoul, Korea. J Crohn’s Colitis. 2022;16(2):207–215. doi:10.1093/ecco-jcc/jjab132
   Google Scholar
• Lo B, Vester-Andersen MK, Vind I, et al. Changes in disease behaviour and location in patients With Crohn’s disease after seven years of follow-up: a Danish population-based inception cohort. J Crohn’s Colitis. 2018;12(3):265–272. doi:10.1093/ecco-jcc/jjx138
   Google Scholar
• Kurowski JA, Milinovich A, Ji X, et al. Differences in biologic utilization and surgery rates in pediatric and adult Crohn’s Disease: results from a large electronic medical record-derived cohort. Inflamm Bowel Dis. 2021;27(7):1035–1044. doi:10.1093/ibd/izaa239
   PubMed Web of Science ®Google Scholar
• Hirten RP, Lakatos PL, Halfvarson J, et al. A user’s guide to de-escalating immunomodulator and biologic therapy in inflammatory bowel disease. Clin Gastroenterol H. 2020;18(6):1336–1345. doi:10.1016/j.cgh.2019.12.019
   Web of Science ®Google Scholar
• Frei R, Fournier N, Zeitz J, et al. Early Initiation of Anti-TNF is associated with favourable long-term outcome in crohn’s disease: 10-year-follow-up data from the Swiss IBD cohort study. J Crohn’sColitis. 2019;13(10):1292–1301. doi:10.1093/ecco-jcc/jjz057
   PubMed Web of Science ®Google Scholar